Fox Chase Cancer Center Present Research at the ASTRO 2023 Annual Meeting

Fox Chase Building
Fox Chase Cancer Center researchers will participate in the presentation and discussion of 11 research projects at the American Society for Radiation Oncology Annual Meeting.

PHILADELPHIA (October 2, 2023)—Fox Chase Cancer Center researchers will participate in the presentation and discussion of 11 research projects at the American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting, which is being held in San Diego from October 1 - 4, 2023.

Sunday, October 1

2107: The Effect of Stereotactic Body Radiotherapy (SBRT) Dose-Fraction (fx) Schema on Non-Small Cell Lung Cancer (NSCLC); Aneesh Pirlamarla, MD, Fox Chase Cancer Center; Presenter; Sunday, October 1, 2023; 4:45 PM - 6:00 PM; Poster Q&A 01 - Lung Cancer and DEIH; Poster Q&A; Location: Hall B2.

Monday, October 2

2443: Mutations of the BRCA1/2 Genes in Patients with Breast Cancer Do Not Alter Treatment Outcomes Following Radiation Therapy (RT); Zachary Kiss, DO, Fox Chase Cancer Center; Presenter; Monday, October 2, 2023; 3:00 PM - 4:00 PM; Poster Q&A 03 - Breast Cancer and Nonmalignant Disease; Poster Q&A; Location: Hall B2.

2586: Tumor Regression with 5-Aminolevulinic Acid (5-ALA)-Mediated Radiodynamic Therapy (RDT) Using Different Megavoltage Energies; Dae-Myoung Yang, PhD, Fox Chase Cancer Center; Presenter; Monday, October 2, 2023; 5:00 PM - 6:00 PM; Poster Q&A 04 - Biology and PRO; Poster Q&A; Location: Hall B2.

2587: Investigation of Hydrogen Peroxide for 45MV 5-Aminolevulinic Acid-Mediated Radiodynamic Therapy; Dae-Myoung Yang, PhD, Fox Chase Cancer Center; Presenter; Monday, October 2, 2023; 5:00 PM-6:00 PM; Poster Q&A 04 - Biology and PRO; Poster Q&A; Location: Hall B2.

The Role of Physics in Re-Irradiation and Practical Implementation of the Medical Physics Consult Process; Robert Price, PhD, FASTRO, Fox Chase Cancer Center; Speaker; Monday, October 2, 2023; 3:00 PM - 4:00 PM; Clinical Considerations and Practical Approaches to Re-Irradiation; Education; Location: Room 1.

Tuesday, October 3

2829: Liver Fat and Its Association with Time to Biochemical Failure (TTBCF) after Definitive Treatment to the Prostate; Timothy Dougherty, MD, Fox Chase Cancer Center; Presenter; Tuesday, October 3, 2023; 2:30 PM - 3:45 PM; Poster Q&A 06 - Genitourinary Cancer, Patient Safety, and Nursing; Poster Q&A; Location: Hall B2.

2683: Pre-Treatment Trends in Child-Pugh Score as an Indicator of Post-Treatment Survival in Patients Receiving Liver SBRT for HCC; Peter Lee, MD, PhD, Fox Chase Cancer Center; Presenter; Tuesday, October 3, 2023; 12:45 PM - 2:00 PM ; Poster Q&A 05 - Gastrointestinal Cancer and Sarcoma; Poster Q&A; Location: Hall B2.

2771: Prevalence and Predictors of Sexual Dysfunction (SD) after Treatment of Localized Rectal and Anal Cancer (LRAC); Hilario Yankey, MD, MBA, Fox Chase Cancer Center; Presenter; Tuesday, October 3, 2023; 12:45 PM-2:00 PM; Poster Q&A 05 - Gastrointestinal Cancer and Sarcoma; Poster Q&A; Location: Hall B2.

What Does a Pound of Prevention Cost if the Cure is Measured in Ounces? A Case-Based Approach to Approaching CNS Disease in Small Cell Cancer Patients; Stephanie Weiss, MD, FASTRO, Fox Chase Cancer Center; Moderator; Tuesday, October 3, 2023; 5:15 PM - 6:15 PM; EDU 01; Education; Location: Room 31.

How Much Does a Pound of Prevention Cost, and is Cure Measured in Ounces?; Stephanie Weiss, MD, FASTRO, Fox Chase Cancer Center; Speaker, Tuesday, October 3, 2023; 5:15 PM - 6:15 PM; What Does a Pound of Prevention Cost if the Cure is Measured in Ounces? A Case-Based Approach to Approaching CNS Disease in Small Cell Cancer Patients; Education; Location: Room 31.

Introductions; Stephanie Weiss, MD, FASTRO, Fox Chase Cancer Center; Speaker; Tuesday, October 3, 2023; 5:15 PM - 6:15 PM; What Does a Pound of Prevention Cost if the Cure is Measured in Ounces? A Case-Based Approach to Approaching CNS Disease in Small Cell Cancer Patients; Education; Location: Room 31.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427